Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Featured

News
Dietary Recommendations for Patients With Myelofibrosis
04/22/2024

Grace Taylor

Grace Taylor
A balanced diet can help patients with myelofibrosis have more energy, better immune function, and more.
A balanced diet can help patients with myelofibrosis have more energy, better immune function, and more.
A balanced diet can help...
04/22/2024
Journal of Clinical Pathways
Kerry Rogers, MD
Interview
Venetoclax Plus Ibrutinib Combination Therapy for Treating Patients With CLL With Resistance Mutations
04/19/2024

Featuring Kerry Rogers, MD, The Ohio State University

Featuring Kerry Rogers, MD, The Ohio ...
Kerry Rogers, MD, The Ohio State University, discusses results from her study on how Bruton tyrosine kinase (BTK) inhibitors ibrutinib and venetoclax could help eliminate molecular resistance in patients with CLL who have resistance mutations.
Kerry Rogers, MD, The Ohio State University, discusses results from her study on how Bruton tyrosine kinase (BTK) inhibitors ibrutinib and venetoclax could help eliminate molecular resistance in patients with CLL who have resistance mutations.
Kerry Rogers, MD, The Ohio State...
04/19/2024
Journal of Clinical Pathways
Conference Coverage
Cybersecurity, Drug Shortages, and PBMs: Legislative Updates Impacting Oncology
04/12/2024

Grace Taylor

Grace Taylor
A group of health care industry experts recently shared legislative updates from Washington, DC, impacting oncology at the 2024 Community Oncology Conference.
A group of health care industry experts recently shared legislative updates from Washington, DC, impacting oncology at the 2024 Community Oncology Conference.
A group of health care industry...
04/12/2024
Journal of Clinical Pathways
Rose Gerber, MS
Videos
Becoming a Patient Advocate: Tips for Getting Started
04/12/2024

Featuring Rose Gerber, MS

Featuring Rose Gerber, MS
Patient advocate and cancer survivor Rose Gerber shares her experience in cancer patient advocacy and offers tips for those who wish to become advocates.
Patient advocate and cancer survivor Rose Gerber shares her experience in cancer patient advocacy and offers tips for those who wish to become advocates.
Patient advocate and cancer...
04/12/2024
Journal of Clinical Pathways
News
Exploring Novel Therapies in Oncology: Lessons From the Oncology Care Model
04/11/2024

Brandon Twyford

Brandon Twyford
A study presented at the 2024 NCCN Annual Conference gives insight into care quality, cost dynamics, and the evolving landscape of oncologic innovation.
A study presented at the 2024 NCCN Annual Conference gives insight into care quality, cost dynamics, and the evolving landscape of oncologic innovation.
A study presented at the 2024...
04/11/2024
Journal of Clinical Pathways
News
Impact of Care Delays on Health Care Resource Utilization in Patients With Early-Stage Lung Cancer
04/11/2024

Brandon Twyford

Brandon Twyford
Researchers conducted a study on the real-world ramifications of delayed surgical intervention in early-stage non–small cell lung cancer, highlighting the complex relationship between timing of surgery, patient outcomes, and health care...
Researchers conducted a study on the real-world ramifications of delayed surgical intervention in early-stage non–small cell lung cancer, highlighting the complex relationship between timing of surgery, patient outcomes, and health care...
Researchers conducted a study on...
04/11/2024
Journal of Clinical Pathways
AI
News
The Potential for AI in Oncology
04/11/2024
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay...
04/11/2024
Journal of Clinical Pathways
Erin Fox, PharmD
Videos
How Health Care Stakeholders in Oncology Can Prepare for and Manage Drug Shortages
04/08/2024

Featuring Erin Fox, PharmD

Featuring Erin Fox, PharmD
Erin Fox, PharmD, shares steps health care stakeholders can take to mitigate the impact of drug shortages on cancer care.
Erin Fox, PharmD, shares steps health care stakeholders can take to mitigate the impact of drug shortages on cancer care.
Erin Fox, PharmD, shares steps...
04/08/2024
Journal of Clinical Pathways
Robert Stillman, MA, RN
Videos
Best Practices in Care Team Communication Technology: Updates From NCCN 2024
04/06/2024

Featuring Robert Stillman, MA, RN

Featuring Robert Stillman, MA, RN ...
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN,...
04/06/2024
Journal of Clinical Pathways
Anna Halpern, MD
Videos
An Overview of the Benefits and Challenges of Providing Outpatient Oncology Care
04/06/2024

Featuring Anna Halpern, MD

Featuring Anna Halpern, MD
Anna Halpern, MD, discusses her National Comprehensive Cancer Network annual conference session on how to balance inpatient and outpatient oncology care.
Anna Halpern, MD, discusses her National Comprehensive Cancer Network annual conference session on how to balance inpatient and outpatient oncology care.
Anna Halpern, MD, discusses her...
04/06/2024
Journal of Clinical Pathways
Ted Okon, MBA
Videos
Oncology Legislative Updates and Predictions From Capitol Hill: COA 2024
04/05/2024

Featuring Ted Okon, MBA

Featuring Ted Okon, MBA
Ted Okon, MBA, discusses some of the latest pressing issues in Washington that are impacting oncology stakeholders, particularly in the community oncology setting.
Ted Okon, MBA, discusses some of the latest pressing issues in Washington that are impacting oncology stakeholders, particularly in the community oncology setting.
Ted Okon, MBA, discusses some of...
04/05/2024
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

From the Journal

Research Reports
Patient-Reported Outcomes in Hematopoietic Stem Cell Transplant Recipients: Design, Implementation, and Pilot Results
02/21/2024
Christi Ann Hayes, MD
Aricca D. Van Citters, MS
Wenyan Zhao, PhD
Kate L. Caldon
Charlotte M. Coughenour
Tor D. Tosteson, PhD
Anna N. A. Tosteson, PhD
Kenneth R. Meehan, MD
In a recent study, Christi Ann Hayes, MD, and colleagues aimed to define patient-reported outcome measures in patients receiving hematopoietic stem cell transplant.
In a recent study, Christi Ann Hayes, MD, and colleagues aimed to define patient-reported outcome measures in patients receiving hematopoietic stem cell transplant.
In a recent study, Christi Ann...
02/21/2024
Journal of Clinical Pathways
From the Field
Comprehensive Genomic Testing: Tissue Stewardship and Best Practices
02/12/2024
Rebecca A. Previs, MD, MS
Maureen E. Cooper, BS
Kyle C. Strickland, MD
Heidi Ko, DO
Michelle F. Green, PhD
Faezeh Koohestani, PhD
Stephanie Hastings, PhD
Zachary Wallen, PhD
Sarabjot Pabla, PhD
Jeffrey M. Conroy, BS
Mary Nesline, MS
Shengle Zhang, MD
Durga Prasad Dash, PhD
Brian Caveney, MD, JD, MPH
Marcia Eisenberg, PhD
Eric Severson, MD, PhD
Shakti H. Ramkissoon, MD, PhD
Rebecca A. Previs, MD, et al provide an overview of current genomic testing methodologies and offer guidelines on best practices for tissue stewardship and preanalytic practices for successful comprehensive genomic profiling.
Rebecca A. Previs, MD, et al provide an overview of current genomic testing methodologies and offer guidelines on best practices for tissue stewardship and preanalytic practices for successful comprehensive genomic profiling.
Rebecca A. Previs, MD, et al...
02/12/2024
Journal of Clinical Pathways
Perspectives
The Key Factors Driving Low Participation in the Enhancing Oncology Model
02/12/2024
Theresa Dreyer, MPH
Theresa Dreyer, MPH, investigates the challenges leading to a substantial decline in participation among academic oncology practices within the Enhancing Oncology Model.
Theresa Dreyer, MPH, investigates the challenges leading to a substantial decline in participation among academic oncology practices within the Enhancing Oncology Model.
Theresa Dreyer, MPH,...
02/12/2024
Journal of Clinical Pathways
Research Reports
Enhancing Multidisciplinary Team Processes in Lung Cancer Care: A Self-Assessment Toolkit and Best Practices
02/09/2024
Poka Cui
Peter Blanshard
María Teresa Campos-Partera
Adrien Moucquot
S. Hassan R. Naqvi
David Dellamonica
Heather Moses
Poka Cui and colleagues completed a literature review along with interviews involving lung cancer multidisciplinary teams from 24 medical centers across Europe and Canada. In this report, they also introduce a comprehensive self-assessment...
Poka Cui and colleagues completed a literature review along with interviews involving lung cancer multidisciplinary teams from 24 medical centers across Europe and Canada. In this report, they also introduce a comprehensive self-assessment...
Poka Cui and colleagues...
02/09/2024
Journal of Clinical Pathways
Research Reports
The Impact of Social Determinants of Health Beyond Race on Survival in Metastatic Prostate Cancer: A Systematic Literature Review
12/14/2023
Stephen J. Freedland, MD
Imtiaz A. Samjoo, MSc, PhD
Emily Rosta, MSc
Austin Lansing, MSc
Alexandra Hall, MPH
Manvir Rai, BSc
Alexander Niyazov, PharmD, MPH
Jonathan L. Nazari, PharmD
Bhakti Arondekar, PhD, MBA
A systematic literature review by Stephen J. Freedland, MD, and colleagues summarizes the current evidence relating to social determinants of health beyond race and survival in patients with metastatic prostate cancer.
A systematic literature review by Stephen J. Freedland, MD, and colleagues summarizes the current evidence relating to social determinants of health beyond race and survival in patients with metastatic prostate cancer.
A systematic literature review...
12/14/2023
Journal of Clinical Pathways
Research Reports
Clinical and Economic Impact of Implementing HealthPathways at a Musculoskeletal Radiology Department
12/13/2023
Simon R. Davies, MBBCh, MD
Kathleen Lyons, MBBCh
Kausik Mukherjee, MBBS
Ramakrishna Kishore, MBBS
Khurram Hashmi, MBBCh
Maria Dyban, LLM
Anna Kuczynska, MBBCh
Simon R. Davies, MBBCh, and colleagues investigate the impact of HealthPathways on management and primary care clinicians in a musculoskeletal radiology department.
Simon R. Davies, MBBCh, and colleagues investigate the impact of HealthPathways on management and primary care clinicians in a musculoskeletal radiology department.
Simon R. Davies, MBBCh, and...
12/13/2023
Journal of Clinical Pathways
OCPC: IN SESSION
Artificial Intelligence in Oncology: The Wins, The Challenges, and How We Can Deliver on Personalized Cancer Care
09/19/2023
Matthew Biancalana, PhD
Tushar Pandey, MBA
Mathew Biancalana, PhD, and Tushar Pandey, MBA, discuss how artificial intelligence can enhance the field of precision medicine and help unburden physicians from laborious and repetitive tasks in diagnostic analyses.
Mathew Biancalana, PhD, and Tushar Pandey, MBA, discuss how artificial intelligence can enhance the field of precision medicine and help unburden physicians from laborious and repetitive tasks in diagnostic analyses.
Mathew Biancalana, PhD, and...
09/19/2023
Journal of Clinical Pathways
Research Reports
Off-Label Use of Precision Oncology Therapeutics in Advanced Solid Cancers Following Identification of Associated Variants via Multicancer Next-Generation Sequencing Panel: A Real-World Evidence Pilot Study
09/19/2023
Julie Wiedower, PhDc
Nicole Zhang, MPH
Rebecca Nagy, MS
Kathryn Lang, MD
Jayati Saha, PhD, MPH
Julie Wiedower, PhDc, and colleagues analyze the frequency of real-world off-label therapy utilization post–comprehensive genomic profiling via liquid biopsy in precision oncology.
Julie Wiedower, PhDc, and colleagues analyze the frequency of real-world off-label therapy utilization post–comprehensive genomic profiling via liquid biopsy in precision oncology.
Julie Wiedower, PhDc, and...
09/19/2023
Journal of Clinical Pathways
Research Reports
Oncology Pathways Drive Adoption of High-Quality Treatment Regimens and Deliver Drug Cost Savings
08/07/2023
Kathryn Christensen, MS
Timothy Dollear, MD
Rama Al Ghannam, PharmD
Eric Gratias, MD, FAAP
Robinson Ortiz, MD
Stephen Hamilton, MD
Kathryn Christensen, MS, and colleagues share the initial results of the launch of Cigna and eviCore Healthcare’s Oncology Value-based Pathways program.
Kathryn Christensen, MS, and colleagues share the initial results of the launch of Cigna and eviCore Healthcare’s Oncology Value-based Pathways program.
Kathryn Christensen, MS, and...
08/07/2023
Journal of Clinical Pathways
Perspectives
Leveraging Quality Measurement to Drive Equitable Cancer Care for Transgender Individuals
08/07/2023
Elizabeth Donckels, MSPH
Nina Regenold, MSc
Theresa Schmidt, MA
Will Nolan
Scout
Don S. Dizon, MD
Tom Valuck, MD, JD
Elizabeth Donckels, MSPH, and colleagues investigate several measurement tactics to promote cancer care quality improvement for transgender individuals.
Elizabeth Donckels, MSPH, and colleagues investigate several measurement tactics to promote cancer care quality improvement for transgender individuals.
Elizabeth Donckels, MSPH, and...
08/07/2023
Journal of Clinical Pathways

Advertisement

Guideline Updates

Deborah Stephens, DO, University of Utah
Videos
Overview of the Updated NCCN Guidelines on Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
05/17/2023
Deborah Stephens, DO, Huntsman Cancer Institute, University of Utah, and member of the NCCN Guidelines Panel for the Management of CLL, provides an overview of the latest updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN...
Deborah Stephens, DO, Huntsman Cancer Institute, University of Utah, and member of the NCCN Guidelines Panel for the Management of CLL, provides an overview of the latest updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN...
Deborah Stephens, DO, Huntsman...
05/17/2023
Journal of Clinical Pathways
Guideline Updates
NCCN Updates Clinical Practice Guidelines for Multiple Myeloma
01/11/2023

Yvette C. Terrie

Yvette C. Terrie
The NCCN recently published updated recommendations for the management of MM regarding newly diagnosed transplant-eligible and transplant-ineligible patients with MM, maintenance, and previously treated MM, and principles of management of...
The NCCN recently published updated recommendations for the management of MM regarding newly diagnosed transplant-eligible and transplant-ineligible patients with MM, maintenance, and previously treated MM, and principles of management of...
The NCCN recently published...
01/11/2023
Journal of Clinical Pathways
Guideline Updates
NCCN Updates Clinical Practice Guidelines in Thyroid Carcinoma
09/08/2022

Yvette C Terrie

Yvette C Terrie
The National Comprehensive Cancer Network recently published updated recommendations regarding management of medullary thyroid carcinoma and anaplastic thyroid carcinoma, along with surgical management of differentiated thyroid carcinoma.
The National Comprehensive Cancer Network recently published updated recommendations regarding management of medullary thyroid carcinoma and anaplastic thyroid carcinoma, along with surgical management of differentiated thyroid carcinoma.
The National Comprehensive...
09/08/2022
Journal of Clinical Pathways
Guideline Updates
NCCN Updates Therapy Guidelines in Bladder Cancer
08/26/2022

Yvette C Terrie

Yvette C Terrie
NCCN Guidelines Panel for Bladder Cancer presented data evaluating new treatment options in bladder cancer, as well as relevant updates to the NCCN Clinical Practice Guidelines in Oncology for Bladder Cancer.
NCCN Guidelines Panel for Bladder Cancer presented data evaluating new treatment options in bladder cancer, as well as relevant updates to the NCCN Clinical Practice Guidelines in Oncology for Bladder Cancer.
NCCN Guidelines Panel for...
08/26/2022
Journal of Clinical Pathways

Advertisement

Advertisement

Videos

Rose Gerber, MS
Videos
Becoming a Patient Advocate: Tips for Getting Started
04/12/2024

Featuring Rose Gerber, MS

Featuring Rose Gerber, MS
Patient advocate and cancer survivor Rose Gerber shares her experience in cancer patient advocacy and offers tips for those who wish to become advocates.
Patient advocate and cancer survivor Rose Gerber shares her experience in cancer patient advocacy and offers tips for those who wish to become advocates.
Patient advocate and cancer...
04/12/2024
Journal of Clinical Pathways
John Allan, MD, Weill Cornell Medicine
Conference Coverage
Comparing BTK Inhibitors for Frontline Chronic Lymphocytic Leukemia Treatment
04/10/2024

Featuring John Allan, MD

Featuring John Allan, MD
John Allan, MD, compares the use of different BTK inhibitors for the treatment of CLL in a frontline setting and discusses whether there is an optimal drug regimen to use among patients with CLL.
John Allan, MD, compares the use of different BTK inhibitors for the treatment of CLL in a frontline setting and discusses whether there is an optimal drug regimen to use among patients with CLL.
John Allan, MD, compares the use...
04/10/2024
Lymphoma, Leukemia & Myeloma Network
Erin Fox, PharmD
Videos
How Health Care Stakeholders in Oncology Can Prepare for and Manage Drug Shortages
04/08/2024

Featuring Erin Fox, PharmD

Featuring Erin Fox, PharmD
Erin Fox, PharmD, shares steps health care stakeholders can take to mitigate the impact of drug shortages on cancer care.
Erin Fox, PharmD, shares steps health care stakeholders can take to mitigate the impact of drug shortages on cancer care.
Erin Fox, PharmD, shares steps...
04/08/2024
Journal of Clinical Pathways
Robert Stillman, MA, RN
Videos
Best Practices in Care Team Communication Technology: Updates From NCCN 2024
04/06/2024

Featuring Robert Stillman, MA, RN

Featuring Robert Stillman, MA, RN ...
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN,...
04/06/2024
Journal of Clinical Pathways
Anna Halpern, MD
Videos
An Overview of the Benefits and Challenges of Providing Outpatient Oncology Care
04/06/2024

Featuring Anna Halpern, MD

Featuring Anna Halpern, MD
Anna Halpern, MD, discusses her National Comprehensive Cancer Network annual conference session on how to balance inpatient and outpatient oncology care.
Anna Halpern, MD, discusses her National Comprehensive Cancer Network annual conference session on how to balance inpatient and outpatient oncology care.
Anna Halpern, MD, discusses her...
04/06/2024
Journal of Clinical Pathways
Ted Okon, MBA
Videos
Oncology Legislative Updates and Predictions From Capitol Hill: COA 2024
04/05/2024

Featuring Ted Okon, MBA

Featuring Ted Okon, MBA
Ted Okon, MBA, discusses some of the latest pressing issues in Washington that are impacting oncology stakeholders, particularly in the community oncology setting.
Ted Okon, MBA, discusses some of the latest pressing issues in Washington that are impacting oncology stakeholders, particularly in the community oncology setting.
Ted Okon, MBA, discusses some of...
04/05/2024
Journal of Clinical Pathways
Hamza Hashmi, MD
Videos
Recent Advancements in Myeloma Treatment Changing the Standard of Care
04/04/2024

Featuring Hamza Hashmi, MD

Featuring Hamza Hashmi, MD
Hamza Hashmi, MD, Memorial Sloan Kettering Cancer Center, shares insights on recent advancements in myeloma treatment and gives a preview of his session on managing myeloma at the 2024 Community Oncology Conference.
Hamza Hashmi, MD, Memorial Sloan Kettering Cancer Center, shares insights on recent advancements in myeloma treatment and gives a preview of his session on managing myeloma at the 2024 Community Oncology Conference.
Hamza Hashmi, MD, Memorial Sloan...
04/04/2024
Journal of Clinical Pathways
Edward Arrowsmith, MD
Videos
Innovations in Oncology Pathways at the Community Oncology Conference
04/03/2024

Featuring Edward Arrowsmith, MD

Featuring Edward Arrowsmith, MD ...
Edward Arrowsmith, MD, provides insight into the development of clinical pathways at OneOncology and shares highlights from the 2024 Community Oncology Conference.
Edward Arrowsmith, MD, provides insight into the development of clinical pathways at OneOncology and shares highlights from the 2024 Community Oncology Conference.
Edward Arrowsmith, MD, provides...
04/03/2024
Journal of Clinical Pathways
BDHC thumbnail
Breaking Down Health Care
The Government and Health Care: A Volatile or Necessary Mix?
04/01/2024

Featuring Michael Kolodziej, MD, and John Hennessy, MBA

Featuring Michael Kolodziej, MD, and ...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, cover the US federal government’s role in health care—Medicare, Medicaid, and the Affordable Care Act. They discuss the benefits, challenges, and...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, cover the US federal government’s role in health care—Medicare, Medicaid, and the Affordable Care Act. They discuss the benefits, challenges, and...
In this Breaking Down Health...
04/01/2024
Cancer Care Business Exchange
Nikolai Podoltsev video thumbnail.
Videos
Current Treatment Options and Recent Developments in Myelofibrosis
03/27/2024

Featuring Nikolai Podoltsev, MD, PhD

Featuring Nikolai Podoltsev, MD, PhD ...
Nikolai Podoltsev, MD, PhD, shares key insights from his session on managing myelofibrosis at ASH 2023 and looks at some of the exciting research on the horizon.
Nikolai Podoltsev, MD, PhD, shares key insights from his session on managing myelofibrosis at ASH 2023 and looks at some of the exciting research on the horizon.
Nikolai Podoltsev, MD, PhD,...
03/27/2024
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Features

Research Reports
Patient-Reported Outcomes in Hematopoietic Stem Cell Transplant Recipients: Design, Implementation, and Pilot Results
02/21/2024
Christi Ann Hayes, MD
Aricca D. Van Citters, MS
Wenyan Zhao, PhD
Kate L. Caldon
Charlotte M. Coughenour
Tor D. Tosteson, PhD
Anna N. A. Tosteson, PhD
Kenneth R. Meehan, MD
In a recent study, Christi Ann Hayes, MD, and colleagues aimed to define patient-reported outcome measures in patients receiving hematopoietic stem cell transplant.
In a recent study, Christi Ann Hayes, MD, and colleagues aimed to define patient-reported outcome measures in patients receiving hematopoietic stem cell transplant.
In a recent study, Christi Ann...
02/21/2024
Journal of Clinical Pathways
From the Field
Comprehensive Genomic Testing: Tissue Stewardship and Best Practices
02/12/2024
Rebecca A. Previs, MD, MS
Maureen E. Cooper, BS
Kyle C. Strickland, MD
Heidi Ko, DO
Michelle F. Green, PhD
Faezeh Koohestani, PhD
Stephanie Hastings, PhD
Zachary Wallen, PhD
Sarabjot Pabla, PhD
Jeffrey M. Conroy, BS
Mary Nesline, MS
Shengle Zhang, MD
Durga Prasad Dash, PhD
Brian Caveney, MD, JD, MPH
Marcia Eisenberg, PhD
Eric Severson, MD, PhD
Shakti H. Ramkissoon, MD, PhD
Rebecca A. Previs, MD, et al provide an overview of current genomic testing methodologies and offer guidelines on best practices for tissue stewardship and preanalytic practices for successful comprehensive genomic profiling.
Rebecca A. Previs, MD, et al provide an overview of current genomic testing methodologies and offer guidelines on best practices for tissue stewardship and preanalytic practices for successful comprehensive genomic profiling.
Rebecca A. Previs, MD, et al...
02/12/2024
Journal of Clinical Pathways
Perspectives
The Key Factors Driving Low Participation in the Enhancing Oncology Model
02/12/2024
Theresa Dreyer, MPH
Theresa Dreyer, MPH, investigates the challenges leading to a substantial decline in participation among academic oncology practices within the Enhancing Oncology Model.
Theresa Dreyer, MPH, investigates the challenges leading to a substantial decline in participation among academic oncology practices within the Enhancing Oncology Model.
Theresa Dreyer, MPH,...
02/12/2024
Journal of Clinical Pathways
Research Reports
Enhancing Multidisciplinary Team Processes in Lung Cancer Care: A Self-Assessment Toolkit and Best Practices
02/09/2024
Poka Cui
Peter Blanshard
María Teresa Campos-Partera
Adrien Moucquot
S. Hassan R. Naqvi
David Dellamonica
Heather Moses
Poka Cui and colleagues completed a literature review along with interviews involving lung cancer multidisciplinary teams from 24 medical centers across Europe and Canada. In this report, they also introduce a comprehensive self-assessment...
Poka Cui and colleagues completed a literature review along with interviews involving lung cancer multidisciplinary teams from 24 medical centers across Europe and Canada. In this report, they also introduce a comprehensive self-assessment...
Poka Cui and colleagues...
02/09/2024
Journal of Clinical Pathways
Research Reports
The Impact of Social Determinants of Health Beyond Race on Survival in Metastatic Prostate Cancer: A Systematic Literature Review
12/14/2023
Stephen J. Freedland, MD
Imtiaz A. Samjoo, MSc, PhD
Emily Rosta, MSc
Austin Lansing, MSc
Alexandra Hall, MPH
Manvir Rai, BSc
Alexander Niyazov, PharmD, MPH
Jonathan L. Nazari, PharmD
Bhakti Arondekar, PhD, MBA
A systematic literature review by Stephen J. Freedland, MD, and colleagues summarizes the current evidence relating to social determinants of health beyond race and survival in patients with metastatic prostate cancer.
A systematic literature review by Stephen J. Freedland, MD, and colleagues summarizes the current evidence relating to social determinants of health beyond race and survival in patients with metastatic prostate cancer.
A systematic literature review...
12/14/2023
Journal of Clinical Pathways

Columns

Transformative Employer Trends
Shared Decision-Making on Health Care Risks
03/27/2024
F. Randy Vogenberg, PhD, FASHP
This column explores the purpose behind managing risk and determining how conflict around care cost management can occur, including through the use of pathways.
This column explores the purpose behind managing risk and determining how conflict around care cost management can occur, including through the use of pathways.
This column explores the purpose...
03/27/2024
Journal of Clinical Pathways
MAI Mindset
December 2023 Pathways Impact Study Part 2: Impact of Pathway Programs on Treatment Selection
03/27/2024
Lee Blansett, MBA
This entry of our MAI Mindset column summarizes the second part of a study by HMP Market Access Insights, which examined the influence and impact pathways have on oncologists’ treatment decisions.
This entry of our MAI Mindset column summarizes the second part of a study by HMP Market Access Insights, which examined the influence and impact pathways have on oncologists’ treatment decisions.
This entry of our MAI Mindset...
03/27/2024
Journal of Clinical Pathways
Editor's Page
Patient-Centric Care in Precision Medicine: Overcoming Barriers, Embracing Innovation
03/27/2024
Winston Wong, PharmD, Editor-in-Chief
Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, including current trends in the utilization of biomarker testing and patient-reported outcome measures.
Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, including current trends in the utilization of biomarker testing and patient-reported outcome measures.
Editor-in-Chief Winston Wong,...
03/27/2024
Journal of Clinical Pathways
MAI Mindset
December 2023 Pathways Impact Study Part 1: Awareness and Influencers of Use
02/12/2024
Lee Blansett, MBA
In this entry of our MAI Mindset column, Lee Blansett, MBA, summarizes a study by HMP Market Access Insights, which examined the influence and impact pathways have on oncologists’ treatment decisions.
In this entry of our MAI Mindset column, Lee Blansett, MBA, summarizes a study by HMP Market Access Insights, which examined the influence and impact pathways have on oncologists’ treatment decisions.
In this entry of our MAI Mindset...
02/12/2024
Journal of Clinical Pathways
Engaging Payers
How to Support the Adoption and Integration of Specialty Value-Based Care Models: A Conversation Across Multiple Stakeholders
02/09/2024
Lili Brillstein, MPH
Lili Brillstein, MPH, discusses key points from the 2023 Healthcare Innovations Summit held in Aspen, Colorado, regarding the barriers to implementing value-based care models for specialty care, and what can be done to overcome them and...
Lili Brillstein, MPH, discusses key points from the 2023 Healthcare Innovations Summit held in Aspen, Colorado, regarding the barriers to implementing value-based care models for specialty care, and what can be done to overcome them and...
Lili Brillstein, MPH, discusses...
02/09/2024
Journal of Clinical Pathways

Departments

Conference Highlights
Highlights From the 65th ASH Annual Meeting & Exposition
02/09/2024
The American Society of Hematology Annual Meeting & Exposition was held in San Diego, California, December 9-12, 2023. Read our selection of online news coverage of the conference that features the discoveries, emerging therapies, and...
The American Society of Hematology Annual Meeting & Exposition was held in San Diego, California, December 9-12, 2023. Read our selection of online news coverage of the conference that features the discoveries, emerging therapies, and...
The American Society of...
02/09/2024
Journal of Clinical Pathways
Conference Highlights
Key Highlights From CPC+CBEx 2023
12/14/2023
The Clinical Pathways Congress + Cancer Care Business Exchange annual meeting was held in Boston, October 6-8, 2023. Topics included the role of AI in oncology, challenges in clinical trial recruitment, and more.
The Clinical Pathways Congress + Cancer Care Business Exchange annual meeting was held in Boston, October 6-8, 2023. Topics included the role of AI in oncology, challenges in clinical trial recruitment, and more.
The Clinical Pathways Congress +...
12/14/2023
Journal of Clinical Pathways
Corrigendum
Corrigendum: The Economic Impact of Treatment Sequences for Chronic Lymphocytic Leukemia in the United States: A Cost of Care and Budget Impact Model of Venetoclax Plus Obinutuzumab Sequences
12/14/2023
In the June 2022 issue of the Journal of Clinical Pathways, there were errors in the article by Davids et al. The online version of the article has been updated.
In the June 2022 issue of the Journal of Clinical Pathways, there were errors in the article by Davids et al. The online version of the article has been updated.
In the June 2022 issue of the...
12/14/2023
Journal of Clinical Pathways
Clinical Pathways Forum
Beyond Adherence: Clinical Pathways at Roswell Park
12/13/2023
Mishellene McKinney, MHA, RN, OCN—Column Editor
For the August 2023 Clinical Pathways Forum, Stephen B. Edge, MD, addressed the forum with an update on the clinical pathways program at Roswell Park Comprehensive Cancer Center.
For the August 2023 Clinical Pathways Forum, Stephen B. Edge, MD, addressed the forum with an update on the clinical pathways program at Roswell Park Comprehensive Cancer Center.
For the August 2023 Clinical...
12/13/2023
Journal of Clinical Pathways
Clinical Pathways Forum
Precision Medicine Testing in Oncology: Benefits of and Barriers to Adoption
09/19/2023
Mishellene McKinney, MHA, RN, OCN—Column Editor
For the May 2023 Clinical Pathways Forum, Suzzette Arnal, PhD, addressed the Forum about precision medicine and how The US Oncology Network has worked to increase precision medicine testing across their organization.
For the May 2023 Clinical Pathways Forum, Suzzette Arnal, PhD, addressed the Forum about precision medicine and how The US Oncology Network has worked to increase precision medicine testing across their organization.
For the May 2023 Clinical...
09/19/2023
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP March/April 2024

Current Issue

April 2024
Volume 10
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement